Recently, Meier et al. reported GFAP imaging findings using 125I-labeled E9 nanobody derivatives in a transgenic mouse model with amyloid pathology and neuroinflammation (ArcSwe) [38]. This evidence concerns the gene GFAP and amyloidosis.